BHVN vs ELV · $1.66B cap vs P/E 18, rev $199.13B
Biohaven Ltd. (BHVN) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Biohaven Ltd. (BHVN) is a biotechnology company listed on US.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
BHVN does not have a complete income-statement cache yet.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
BHVN currently screens at market cap $1.66B. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the BHVN and ELV stock pages for the full models.
Not investment advice.